Abstract:
The present invention provides new and structurally diverse compositions comprising compounds of general formula (I), wherein A is N-G or P-G; B is N or P; C is N-G, P-G or -[CH(R7)]q-; D is N or P; E is N-F or P-F; F is -[CH(R8)]p-N(G)2 or -[CH(R8)]p-P(G)2; G is -[CH(R9)]r-X or -[CH(R9)]s-N[CH(R10)t-X]2; X is -CO2H, -OPO3H2, -PO3H2, -SO3H, -SH, -OH, or -CONHOH; R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 may be the same or different and are hydrogen, C1-8 alkyl, or C6-10 aryl, optionally substituted by one or more hydroxy, C1-8 alkyl, C1-8 hydroxyalkyl, C1-8 alkoxy, C6-10 aryl, C6-10 hydroxyaryl, C6-10 aryloxy, -CO2R11, -CONR12R13, or -NR14R15 groups; R11, R12, R13, R14 and R15 may be the same or different and are hydrogen, C1-8 alkyl, C1-8 hydroxyalkyl, or C1-8 alkoxyalkyl; R14 and R15 may form a 5 or 6 membered carbocyclic ring optionally containing singularly or in combination nitrogen, oxygen or sulfur; i, j, k, l, m, n, p, q, r, s and t may be the same or different and are zero to about 5. Methods for imaging using compositions of the invention are also provided.
Abstract translation:本发明提供包含通式(I)化合物的新的和结构不同的组合物,其中A是N-G或P-G; B是N或P; C是N-G,P-G或 - [CH(R7)] q-; D为N或P; E是N-F或P-F; F是 - [CH(R8)] p-N(G)2或 - [CH(R8)] p-P(G)2; G是 - [CH(R 9)] r -X或 - [CH(R 9)] s -N [CH(R 10)t -X] 2; X是-CO 2 H,-OPO 3 H 2,-PO 3 H 2,-SO 3 H,-SH,-OH或-CONHOH; R 1,R 2,R 3,R 4,R 5,R 6,R 7,R 8,R 9和R 10可以相同或不同,为氢,C 1-8烷基或C 6-10芳基,任选地被一个或多个羟基, C 1-8烷基,C 1-8羟基烷基,C 1-8烷氧基,C 6-10芳基,C 6-10羟基芳基,C 6-10芳氧基,-CO 2 R 11,-CONR 12 R 13或-NR 14 R 15基团; R 11,R 12,R 13,R 14和R 15可以相同或不同,为氢,C 1-8烷基,C 1-8羟基烷基或C 1-8烷氧基烷基; R 14和R 15可以形成任选地单独或组合地含有氮,氧或硫的5或6元碳环; i,j,k,l,m,n,p,q,r,s和t可以相同或不同,为零至约5.还提供使用本发明组合物成像的方法。
Abstract:
A method of enhancing a magnetic resonance signal comprising the steps of administering a quantity of a selected magnetic isotope to a living biological tissue at a concentration greater than the naturally occurring concentration of such isotope and detecting magnetic resonance signal from the administered magnetic isotope in the living biological tissue.
Abstract:
A negative contrast agent for MRI is an aqueous suspension having a quantity of barium sulfate between 25 and 40 percent by weight and a quantity of bentonite between two and four percent by weight. Such a negative contrast agent provides dark imaging in a T2 weighted pulse sequence; namely a relative signal intensity (RSI) approaching zero. It also provides a relative signal intensity (RSI) of under thirty percent of that of a reference that approximates tissue in a T1 weighted pulse sequence.
Abstract:
The sensor device is intended to be implemented at the vicinity or inside a nuclear magnetic resonance apparatus, and more particularly on a patient inside the canal of the magnet of a magnetic resonance imager (MRI), characterized in that it is essentially comprised of, on the one hand, at least two non-metal electrodes (1) intended to be applied to the skin of a patient (2), and on the other hand, of an electro-optical conversion, amplification and filtering module (3) for the electric signals received from the heart by means of the electrodes (1), said module being arranged in a shielded casing (4) forming a Faraday cage, and optically connected to a display and/or monitoring apparatus and, finally, comprising a support body (6) made of non-magnetic material, carrying the electrode (1) and the shielded casing (4) containing the module (3).
Abstract:
Organic compounds for diagnostic imaging which contain at least one aryl group which has been derivatized to contain at least one perfluoro-1H,1H-neopentyl moiety are provided. The perfluoro-1H, 1H-neopentyl groups produce a single magnetic resonance to insure a maximum signal to noise ratio. One compound disclosed is 2-O-oleoylglycerol 1,3-bis(7'-{3",5"-di[2"',2"'-di(trifluoromethyl)3"',3"',3"'-trifluoropropyl]phenyl}heptanoate). In the preferred embodiment, a lipid emulsion is provided as a carrier vehicle to deliver the derivitized analog to a mammalian recipient. Methods to use these compounds in MRI and computerized tomography are provided.
Abstract:
The invention provides a specific measure of iron stores in vivo using magnetic resonance imaging. T2 relaxation times in both lower-to-mid field strength magnetic resonance imaging instruments and a higher field strength instrument is evaluated. T2 obtained at the higher field strength instrument is subtracted from T2 obtained at the lower field strength instrument. This difference, T, is then correlated with a quantitative measure of the iron stores in vivo in the scanned tissue. A two-dimensional or multidimensional map of the scanned tissue is then constructed on the basis of T to visually identify different tissue types as being normal or abnormal, either through a visual determination based on gray scales or a numeric comparison based on quantitative measure. The introduction of artificial or nonbiological substances as opposed to natural ferritin, is permitted for further diagnostic use by application of this methodology.
Abstract:
A coil unit for generating a gradient magnetic field on an opposed type magnet comprises two coils through which spiral currents flow in opposite directions. The two coils are disposed on opposite sides of a region where a gradient magnetic field is generated. The linearity of the gradient magnetic field is improved without increasing inductance of the coil. Each of the mutually opposed coils includes a plurality of substantially circular and substantially concentric current paths, which are connected to form a spiral coil. The coil has a current distribution in which current density is low near its center and high near its periphery. The pitch of the spiral is substantially inversely proportional to the current distribution.
Abstract:
The present invention relates to apparatus and a method for imaging and heating body tissues with one probe (100), through use of a magnetic resonance imaging radio frequency source (110). The device may also be configured with a thermocouple (360) to provide temperature-controlled heat therapy with sufficient image definition to control that therapy.
Abstract:
A method of magnetic resonance imaging (MRI) is disclosed which employs a diamagnetic contrast agent comprising gas-carrying, non-magnetic microparticles, which are preferably microspheres consisting of minute gas bubbles encapsulated by stabilized bicompatible material. The method is especially useful in imaging the vascular system as in angiography or venography.
Abstract:
Measurement positions of measured magnetic resonance signals on a Fourier plane form a distorted square matrix due to influence of an inclined magnetic field which changes non-linearly due to eddy currents. According to present invention, the distortion is corrected by interpolation in order to obtain virtual data on a square matrix, the data corresponding to the measurement positions of magnetic resonance signals obtained when an idel inclined magnetic field is applied; and image data free from blur is obtained by Fourier transformation of the virtual data.